217 Publications (Page 6 of 9)
2013
Support service use and interest in support services among distressed family caregivers of lung cancer patients.Mosher, Catherine E⋅Champion, Victoria L⋅Hanna, Nasser⋅Jalal, Shadia I⋅Fakiris, Achilles J⋅Birdas, Thomas J⋅Okereke, Ikenna⋅Kesler, Kenneth A⋅Einhorn, Lawrence H⋅Given, Barbara A⋅Monahan, Patrick O and Ostroff, Jamie SPsycho-oncology, vol. 22, (no. 7), pp. 1549-56, 2013/Jul.
| Journal Article
Support service use and interest in support services among lung cancer patients.Mosher, Catherine E⋅Hanna, Nasser⋅Jalal, Shadia I⋅Fakiris, Achilles J⋅Einhorn, Lawrence H⋅Birdas, Thomas J⋅Kesler, Kenneth A and Champion, Victoria LLung cancer (Amsterdam, Netherlands), vol. 82, (no. 1), pp. 162-7, 2013/Oct.
| Journal Article
Tobacco cessation and control a decade later: American society of clinical oncology policy statement update.Hanna, Nasser⋅Mulshine, James⋅Wollins, Dana S⋅Tyne, Courtney and Dresler, CarolynJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, (no. 25), pp. 3147-3157, September 1, 2013.
| Journal Article
2012
A double-blind randomized discontinuation phase-II study of sorafenib (BAY 43-9006) in previously treated non-small-cell lung cancer patients: eastern cooperative oncology group study E2501.Wakelee, Heather A⋅Lee, Ju-Whei⋅Hanna, Nasser H⋅Traynor, Anne M⋅Carbone, David P and Schiller, JoanJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 7, (no. 10), pp. 1574-82, 2012/Oct.
| Journal Article
A Double-Blind Randomized Discontinuation Phase-II Study of Sorafenib (BAY 43–9006) in Previously Treated Non–Small-Cell Lung Cancer Patients: Eastern Cooperative Oncology Group Study E2501Wakelee, Heather A⋅Wakelee, Heather A.⋅Lee, Ju-Whei⋅Lee, Ju-Whei⋅Hanna, Nasser H⋅Hanna, Nasser H.⋅Traynor, Anne M.⋅Traynor, Anne M⋅Carbone, David P.⋅Carbone, David P⋅Schiller, Joan H. and Schiller, Joan HJournal of Thoracic Oncology, vol. 7, (no. 10), pp. 1582, October 2012.
| Journal Article
A retrospective analysis of patients with intermediate-risk germ cell tumor (IRGCT) treated at Indiana University from 2000 to 2010Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Satpute, Shailesh R⋅Satpute, Shailesh R⋅Satpute, Shailesh R⋅Brames, Mary J⋅Brames, Mary J⋅Brames, Mary J⋅Suleiman, Yaman⋅Suleiman, Yaman⋅Suleiman, Yaman⋅Al Nasrallah, Nawar⋅Al Nasrallah, Nawar⋅Al Nasrallah, Nawar⋅Perkins, Susan M⋅Perkins, Susan M⋅Perkins, Susan M⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 4534, 2012-05-20.
| Journal Article
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.Ortuzar, Waldo⋅Hanna, Nasser⋅Pennella, Eduardo⋅Peng, Guangbin⋅Langer, Corey⋅Monberg, Matthew and Scagliotti, GiorgioClinical lung cancer, vol. 13, (no. 1), pp. 24-30, January 2012.
| Journal Article
Sunitinib plus paclitaxel in patients with advanced esophageal cancer: a phase II study from the Hoosier Oncology Group.Schmitt, Jordan M⋅Schmitt, Jordan M⋅Sommers, Scott R⋅Sommers, Scott R⋅Fisher, William⋅Fisher, William⋅Ansari, Rafat⋅Ansari, Rafat⋅Robin, Erwin⋅Robin, Erwin⋅Koneru, Karuna⋅Koneru, Karuna⋅McClean, John⋅McClean, John⋅Liu, Ziyue⋅Liu, Ziyue⋅Tong, Yan⋅Tong, Yan⋅Hanna, Nasser and Hanna, NasserJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 7, (no. 4), pp. 760-3, 2012/Apr.
| Journal Article
Three-arm randomized phase II study of carboplatin (C) and paclitaxel (P) in combination with cetuximab (CET), IMC-A12, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508)Hanna, Nasser H⋅Dahlberg, Suzanne Eleanor⋅Kolesar, Jill⋅Hirsch, Fred R⋅Ramalingam, Suresh S and Schiller, Joan HJournal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 7516, 2012-05-20.
| Journal Article
Two drugs versus one drug in non-small-cell lung cancer: are we asking the right questions?Hanna, Nasser HJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 36), pp. 4454-5, 2012/Dec/20.
| Journal Article
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology.Jalal, Shadia I⋅Riggs, H D⋅Melnyk, A⋅Richards, D⋅Agarwala, A⋅Neubauer, M⋅Ansari, R⋅Govindan, Ramaswamy⋅Bruetman, D⋅Fisher, W⋅Breen, T⋅Johnson, C S⋅Yu, Menggang⋅Einhorn, Lawrence H and Hanna, NAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 23, (no. 7), pp. 1730-8, 2012/Jul.
| Journal Article
2011
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.Tan, Eng-Huat⋅Goss, Glenwood D⋅Salgia, Ravi⋅Besse, Benjamin⋅Gandara, David R⋅Hanna, Nasser H⋅Yang, James C⋅Thertulien, Raymond⋅Wertheim, Michael⋅Mazieres, Julien⋅Hensing, Thomas⋅Lee, Christa⋅Gupta, Neeraj⋅Pradhan, Rajendra⋅Qian, Jiang⋅Qin, Qin⋅Scappaticci, Frank A⋅Ricker, Justin L⋅Carlson, Dawn M and Soo, Ross AJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 6, (no. 8), pp. 1418-25, 2011/Aug.
| Journal Article
Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.Schmitt, J M⋅Sommers, S R⋅Fisher, W B⋅Ansari, R H⋅Robin, E L⋅Koneru, K⋅McClean, J W⋅Liu, Z and Hanna, N HJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 29, (no. 15_suppl), pp. e14661, May 20, 2011.
| Journal Article
2010
Advanced non-small cell lung cancer: the role of maintenance therapy.Agarwala, Anuj K and Hanna, Nasser HTherapeutic advances in medical oncology, vol. 2, (no. 1), pp. 17-23, 2010/Jan.
| Journal Article
Dimensional versus categorical use of the PHQ-9 depression scale among persons with non-small-cell lung cancer: a pilot study including quality-of-life comparisons.Whitney, Kriscinda A⋅Whitney, K.A.⋅Steiner, Amy R⋅Steiner, A.R.⋅Lysaker, P.H.⋅Lysaker, Paul H⋅Estes, D.D.⋅Estes, Deborah D⋅Hanna, Nasser H and Hanna, N.H.The journal of supportive oncology, vol. 8, (no. 5), pp. 219-26, 2010 Sep-Oct.
| Journal Article
Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.Barriger, R B⋅Fakiris, Achilles⋅Hanna, Nasser H⋅Yu, Menggang⋅Mantravadi, Prasad and Mc Garry, Ronald CInternational journal of radiation oncology, biology, physics, vol. 78, (no. 5), pp. 1381-6, 2010/Dec/1.
| Journal Article
Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study from the Hoosier Oncology GroupJalal, Shadia⋅Jalal, Shadia I⋅Bedano, Pablo⋅Bedano, Pablo⋅Einhorn, Lawrence⋅Einhorn, Lawrence H⋅Bhatia, Sumeet⋅Bhatia, Sumeet⋅Ansari, Rafat⋅Ansari, Rafat⋅Bechar, Naftali⋅Bechar, Naftali⋅Koneru, Karuna⋅Koneru, Karuna⋅Govindan, Ramaswamy⋅Govindan, Ramaswamy⋅Wu, Jingwei⋅Wu, Jingwei⋅Yu, Menggang⋅Yu, Menggang⋅Schneider, Bryan P⋅Schneider, Bryan⋅Hanna, Nasser and Hanna, NasserJournal of Thoracic Oncology, vol. 5, (no. 12), pp. 2011, December 2010.
| Journal Article
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung CancerScagliotti, Giorgio⋅Novello, Silvia⋅Pawel, Joachim⋅Reck, Martin⋅Pereira, José⋅Thomas, Michael⋅Miziara, José⋅Balint, Beatrix⋅Marinis, Filippo⋅Keller, Alan⋅Arén, Osvaldo⋅Csollak, Maria⋅Albert, Istvan⋅Barrios, Carlos⋅Grossi, Francesco⋅Krzakowski, Maciej⋅Cupit, Lisa⋅Cihon, Frank⋅DiMatteo, Sandra and Hanna, NasserJournal of Clinical Oncology, vol. 28, (no. 11), pp. 1842, 20100410.
| Journal Article
Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non-Small Cell Lung Cancer PatientsEllis, Peter M⋅Kaiser, Rolf⋅Zhao, Yihua⋅Stopfer, Peter⋅Gyorffy, Steve and Hanna, NasserClinical cancer research : an official journal of the American Association for Cancer Research, vol. 16, (no. 10), pp. 2889, 2010-May-15.
| Journal Article
Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116Casey, Erin M⋅Casey, Erin M⋅Harb, Wael⋅Harb, Wael⋅Bradford, Daniel⋅Bradford, Daniel⋅Bufill, Jose⋅Bufill, Jose⋅Nattam, Sreenivasa⋅Nattam, Sreenivasa⋅Patel, Jyoti⋅Patel, Jyoti D⋅Fisher, William⋅Fisher, William⋅Latz, Jane E⋅Latz, Jane E⋅Li, Xiaochun⋅Li, Xiaochun⋅Wu, Jingwei⋅Wu, Jingwei⋅Hanna, Nasser and Hanna, NasserJournal of Thoracic Oncology, vol. 5, (no. 11), pp. 1820, November 2010.
| Journal Article
Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.Gridelli, Cesare⋅Ardizzoni, Andrea⋅Douillard, Jean-Yves⋅Hanna, Nasser H⋅Manegold, Christian⋅Perrone, Francesco⋅Pirker, Robert⋅Rosell, Rafael⋅Shepherd, Frances A⋅De Petris, Luigi⋅Di Maio, Massimo and de Marinis, FilippoLung cancer (Amsterdam, Netherlands), vol. 68, (no. 3), pp. 319-31, 2010/Jun.
| Journal Article
2009
Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II StudyJalal, Shadia I⋅Jalal, Shadia⋅Ansari, Rafat⋅Ansari, Rafat⋅Govindan, Ramaswamy⋅Govindan, Ramaswamy⋅Bhatia, Sumeet⋅Bhatia, Sumeet⋅Bruetman, Daniel⋅Bruetman, Daniel⋅Fisher, William⋅Fisher, William⋅Masters, Gregory⋅Masters, Gregory⋅White, Angela⋅White, Angela⋅Stover, Daniel⋅Stover, Daniel⋅Yu, Menggang⋅Yu, Menggang⋅Hanna, Nasser and Hanna, NasserJournal of Thoracic Oncology, vol. 4, (no. 1), pp. 96, January 2009.
| Journal Article
Pemetrexed plus Cetuximab in Patients with Recurrent Non-small Cell Lung Cancer (NSCLC): A Phase I/II Study from the Hoosier Oncology GroupJalal, Shadia I⋅Jalal, Shadia⋅Waterhouse, David⋅Waterhouse, David⋅Edelman, Martin J⋅Edelman, Martin J⋅Nattam, Sreenivasa⋅Nattam, Sreenivasa⋅Ansari, Rafat⋅Ansari, Rafat⋅Koneru, Karuna⋅Koneru, Karuna⋅Clark, Romnee⋅Clark, Romnee⋅Richards, Arthur⋅Richards, Arthur⋅Wu, Jingwei⋅Wu, Jingwei⋅Yu, Menggang⋅Yu, Menggang⋅Bottema, Brian⋅Bottema, Brian⋅White, Angela⋅White, Angela⋅Hanna, Nasser and Hanna, NasserJournal of Thoracic Oncology, vol. 4, (no. 11), pp. 1424, November 2009.
| Journal Article
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III StudiesScagliotti, Giorgio⋅Scagliotti, Giorgio⋅Scagliotti, Giorgio⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Fossella, Frank⋅Fossella, Frank⋅Fossella, Frank⋅Sugarman, Katherine⋅Sugarman, Katherine⋅Sugarman, Katherine⋅Blatter, Johannes⋅Blatter, Johannes⋅Blatter, Johannes⋅Peterson, Patrick⋅Peterson, Patrick⋅Peterson, Patrick⋅Simms, Lorinda⋅Simms, Lorinda⋅Simms, Lorinda⋅Shepherd, Frances⋅Shepherd, Frances A and Shepherd, FrancesThe Oncologist, vol. 14, (no. 3), pp. 263, 20090301.
| Journal Article
The role of maintenance chemotherapy in advanced nonsmall cell lung cancerJalal, Shadia I⋅Jalal, Shadia⋅Ademuyiwa, Foluso O⋅Ademuyiwa, Foluso⋅Hanna, Nasser H and Hanna, NasserCurrent Opinion in Oncology, vol. 21, (no. 2), pp. 115, 2009-March.
| Journal Article